Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus (original) (raw)

References

1. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. & Schreiber, R.D. How cells respond to interferons . Annu. Rev. Biochem. 67, 227– 264 (1998).
   Article CAS Google Scholar
2. Kloke, O. & Niederle, N. Development and mechanisms of interferon resistance. Cancer Treat. Rev. 17 Suppl A, 81–88 (1990).
   Article Google Scholar
3. Colamonici, O.R., Domanski, P., Platanias, L.C. & Diaz, M.O. Correlation between interferon (IFN) alpha resistance and deletion of the IFN α/β genes in acute leukemia cell lines suggests selection against the IFN system. Blood 80, 744– 749 (1992).
   CAS PubMed Google Scholar
4. Xu, B., Grandér, D., Sangfelt, O. & Einhorn, S. Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood 84, 1942–1949 (1994).
   CAS PubMed Google Scholar
5. Wong, L.H. et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J. Biol. Chem. 272, 28779–28785 (1997).
   Article CAS Google Scholar
6. Abril, E. et al. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Tissue Antigens 47, 391–398 ( 1996).
   Article CAS Google Scholar
7. Sun, W.H. et al. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 91, 570–576 (1998).
   CAS PubMed Google Scholar
8. Letchworth, G.J., Rodriguez, L.L. & Del cbarrera, J. Vesicular stomatitis. Vet. J. 157, 239–260 (1999).
   Article CAS Google Scholar
9. Belkowski, L.S. & Sen, G.C. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J. Virol. 61, 653–660 (1987).
   CAS PubMed PubMed Central Google Scholar
10. Burke, F. Cytokines (IFNs, TNF-α, IL-2 and IL-12) and animal models of cancer . Cytokines Cell. Mol. Ther. 5, 51– 61 (1999).
    CAS PubMed Google Scholar
11. Thomsen, A.R. et al. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9, 1757–1766 ( 1997).
    Article CAS Google Scholar
12. Huneycutt, B.S., Bi, Z., Aoki, C.J. & Reiss, C.S. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67, 6698–6706 (1993).
    CAS PubMed PubMed Central Google Scholar
13. Coukos, G. et al. Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. Clin. Cancer Res. 5, 1523– 1537 (1999).
    CAS PubMed Google Scholar
14. Smith, R.R., Huebner, R.J., Rowe, W.P., Schatten, W.E. & Thomas, L.B. Studies on the use of viruses in the treatment of carcinomas of the cervix. Cancer 9 , 1211–1218 (1956).
    Article Google Scholar
15. Lorence, R.M. > et al. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. Cancer Res. 54, 6017–6021 (1994).
    CAS PubMed Google Scholar
16. Lorence, R.M. et al. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. J. Natl. Cancer Inst. 86, 1228–1233 ( 1994).
    Article CAS Google Scholar
17. Rothmann, T., Hengstermann, A., Whitaker, N.J., Scheffner, M. & zur Hausen, H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72, 9470–9478 (1998).
    CAS PubMed PubMed Central Google Scholar
18. Shimada, A. et al. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res. 58, 4434– 4438 (1998).
    CAS PubMed Google Scholar
19. Strong, J.E., Coffey, M.C., Tang, D., Sabinin, P. & Lee, P.W. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17, 3351–3362 (1998).
    Article CAS Google Scholar
20. Cassady, K.A., Gross, M. & Roizman, B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J. Virol. 72, 8620–8626 (1998).
    CAS PubMed PubMed Central Google Scholar
21. Cave, D.R., Hendrickson, F.M. & Huang, A.S. Defective interfering virus particles modulate virulence . J. Virol. 55, 366–373 (1985).
    CAS PubMed PubMed Central Google Scholar

Download references